Procter & Gamble to Acquire Thorne for $3.8 Billion to Expand Health and Wellness Portfolio
Procter & Gamble is set to acquire the supplement brand Thorne for $3.8 billion. Shailesh Jejurikar, CEO of Procter & Gamble, stated that the acquisition aims to grow the company's health and wellness division by adding a science-driven brand known for high-quality supplements and personalized health solutions. Thorne, founded in 1984, has built a reputation for scientific rigor and practitioner credibility. The acquisition follows a period of growth for the brand, which saw annual revenue surpass $500 million in 2025. The deal is expected to close later in the calendar year 2026, subject to regulatory approvals. This move positions Procter & Gamble as a leader in the premium wellness space, targeting younger consumers and the growing trend of self-care. The acquisition complements existing brands like Metamucil and Vicks, strengthening the company's healthcare segment, which recently saw flat volume growth.